Highlights
NASDAQ: MCRB       Seres Theraptc
Last Price Today's Change   Day's Range   Trading Volume
27.89   -1.97 (6.60%)  27.19 - 29.70  441,800

Overview

 
Avg Volume (4 weeks):545,755
4 Weeks Range:27.19 - 35.023
4 Weeks Price Volatility (%):
8.94%
52 Weeks Range:2.52 - 35.023
52 Weeks Price Volatility (%):
78.05%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109, the company’s product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-155.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3337  5213  557  159 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BLRX 1.98+0.50 
 AAPL 108.86-6.46 
 NIO 30.58-1.41 
 SQQQ 25.03+1.67 
 SPY 326.54-3.44 
 GE 7.42+0.05 
 TWTR 41.36-11.07 
 F 7.73-0.17 
 CCL 13.71+0.73 
 OAS 0.155-0.014